Please login to the form below
Ipsos
This page shows the latest Ipsos news and features for those working in and with pharma, biotech and healthcare.
COVID-19 infections in England drop by 30% amid national lockdown
Observations come from REACT study led by Imperial College London and Ipsos MORI. ... The research, led by Imperial College London and Ipsos MORI, also found that the overall R rate has dropped below 1 (estimated at 0.88), which means that infections are
Latest news
-
Thousands of EU staffers have left NHS since 2016, says Lib Dems
Another NWC survey – compiled by Ipsos Mori – suggested that more than half (51%) of European Economic Area (EEA) nurses and midwives allowing their NHS registration to lapse cited Brexit as a
-
Report shows benefits of GP at Hand digital service, but concerns too
However the in-depth study by Ipsos MORI and York Health Economics Consortium also confirmed some existing concerns about the service’s introduction to the NHS, showing the service has attracted
-
Ipsos to buy GfK Research divisions
GfK’s innovation arm, which incorporates research in car clinics, VR technology, user experience research, design and consulting, will also be taken over by Ipsos. ... The acquisition will see almost 1, 000 GfK staff join Ipsos across 25 countries,
-
The state of trust
Summing up the study’s findings, Ipsos MORI’s chief executive officer Ben Page concluded: “People are massively wrong about lots of things.”. ... He then detailed an experiment Ipsos MORI carried out about communicating a medical diagnosis and
-
Lilly joins Personal Connected Health Alliance
Samsung, AT&T and IPSOS Healthcare also sign up. Lilly has joined the Personal Connected Health Alliance, a US non-profit organisation that aims to make health and wellness an effortless ... Alongside the pharma firm the PCH Alliance has also welcomed
More from news
Approximately 2 fully matching, plus 24 partially matching documents found.
Latest Intelligence
-
Who needs to be trusted anyway?
According to the leader of a UK pharma trade body, one of the 35 health experts on a panel recruited for Langland by Ipsos MORI in 2021, this rings true.
-
After the wildfire: how will healthcare recover from the pandemic?
real. So in 2020 Langland started working with the global market research agency Ipsos MORI to convene a cross-discipline group of 35 health experts, drawn from business, academia, the health
-
Public is more comfortable with health data sharing if they know it is to support breakthrough treatments and vaccines
In 2016, following the withdrawal of the care.data initiative, IPSOS Mori polling found 54% of people supported commercial organisations accessing their health data, with only 26% opposing.
-
Trust: the ultimate elevator
As demonstrated by research from Ipsos last year (‘How reputation and trust affect purchase decisions and marketing efficiency’), trust provides a halo to brands and acts as an ‘elevator’ of a
-
Focusing on patient-centricity to build trust in pharma
By Marianne Guldbrandsen. A2017 global survey by Ipsos/MORI found that only 48% of the public believe that pharmaceutical companies will treat them fairly.
More from intelligence
Approximately 1 fully matching, plus 9 partially matching documents found.
Latest appointments
-
Research Partnership announces new CEO Gareth Phillips
In his most recent role as UK managing director and head of EMEA at Ipsos, Phillips was the driving force behind a transformation of the healthcare business in Europe, leading the ... Ipsos. Research Partnership’s two co-founding directors, Mary
-
Research Partnership appoints Hannah Osborn to MedTech director role
Osborne has previously worked at Ipsos and IQVIA. Research Partnership has appointed Hannah Osborn as a MedTech director in its London, UK office. ... Previously, she worked for Ipsos as director for its MedTech Asia-Pacific (APAC) team, and for IQVIA as
-
HRW bolsters global management team
GfK Healthcare and Ipsos Healthcare.
-
Future Thinking appoints Mohamed Muhsin as UK pharma head
She joins from AlternativesPharma, where she was head of business development and her previous roles have seen her lead healthcare departments for Ipsos and Kantar TNS.
-
Cello Health Insight bolsters senior team
Eletskaya joins the agency's senior team from Ipsos Mori, a French market research company, where she most recently served as healthcare group head at the firm's London office.
More from appointments
Approximately 1 fully matching, plus 8 partially matching documents found.
Latest from PMHub
-
Research Partnership appoints new CEO
Gareth was previously UK Managing Director and Head of EMEA for Ipsos, one of the world’s leading market research companies. ... Ipsos. At Synovate, he held roles based in the US, UK and Asia, and was the company’s Managing Director of Asia Pacific
-
News: Mandira Kar joins London Headquarters as Qualitative Research Director
Mandira is an expert in ethnography with over 15 years’ experience in market research, and joins from Ipsos Healthcare Ethnography.
-
Power to the People: Why consultation is key for improved patient outcomes
An Ipsos MORI poll for the King’s Fund found that while nearly a third of people said that decisions about treatments and services should be made solely by qualified health
-
Wearables and healthcare
Millenial Myths and Realities. Ipsos MORI; 2017. 3. King RC, Villeneuve E, White RJ, Sherratt RS, Holderbaum W, Harwin WS.
-
Maria Eletskaya joins Cello Health Insight
Eletskaya joins the team from Ipsos Mori in London and before this she worked in her native Russia with Ipsos.
More from PMHub
Approximately 0 fully matching, plus 7 partially matching documents found.
Subscribe to our email news alerts
-
Pharmacovigilance Manager
- Highly competitive salary
- Associate Director - Global Healthcare Consulting
- Highly competitive salary
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
-
Technical Sales Representative
- Highly competitive salary
- Strategy Director - Healthcare Advertising
- Highly competitive salary
-
Senior Medical Writer
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
-
Pharmacovigilance Project Lead
- Highly competitive salary
- MHRA to introduce new UK clinical trials framework
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- Takeda presents positive phase 2b results for TAK-279 in plaque psoriasis
- FDA proposes improvements for oncology clinical trials supporting accelerated approval
- Novo Nordisk and Dewpoint partner on insulin resistance drug candidates
- PMGroup announces launch of new recruitment platform PharmaRole
- Merck reports positive results for Keytruda plus chemotherapy in endometrial cancer
- BioNTech reveals plans to spend about €1bn more on research and development this year
- AstraZeneca’s mild combination asthma reliever approved in UK
- Virtual Patient Engagement Program: A Customer Story
- Putting Skin in the Game at AAD 2023
- Locus Biosciences announces first patient treated in urinary tract infection trial
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Merck reports positive results for Keytruda plus chemotherapy in endometrial cancer
- Takeda presents positive phase 2b results for TAK-279 in plaque psoriasis
- Sanofi/Regeneron’s Dupixent approved by EC for atopic dermatitis in children
- Inizio appoints Stefanie Christmas as global head of DE&I
PMHub
Dice Medical Communications
Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop...
Latest intelligence
- Virtual Patient Engagement Program: A Customer Story
- Our client wanted to better understand the needs, preferences, and treatment gaps among adult patients with a rare genetic disease......
- Humancomms for humancare?
- Paul Hutchings, founder of fox&cat, writes on the role of humour in healthcare comms: PharmaComms 2023...
- Rare diseases: not so rare after all
- The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
